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In recent years S-100β has been used, in a research
context, to identify cerebral injury after cardiac surgery
in preference to the more labor-intensive neuropsycho-
logic evaluations.7,8 Several studies suggest that tran-
sient elevations in levels of serum S-100β protein
reflect subclinical cerebral damage in the absence of
frank neurologic signs.9,10 To date, however, no study
has demonstrated that S-100β levels reflect neuropsy-
chologic performance. The aim of the present study was
to determine whether S-100β could predict early or late
neuropsychologic and functional impairment after
coronary bypass surgery with CPB. We attempted to
avoid noncerebral sources of S-100β by discarding car-
diotomy suction blood.11
Patients and methods
Study patients. With ethics committee approval we
prospectively studied 100 patients undergoing elective first-
time coronary bypass without a previous history of neurolog-
ic events or psychiatric illness. Those with acute coronary
syndromes were excluded to eliminate the added anxiety of a
recent illness. We also excluded patients with renal or hepatic
S urgery with cardiopulmonary bypass (CPB) isassumed to cause subtle cerebral injury that may be
detectable on neuropsychologic measures in 30% to
70% of patients.1-2 Elevation of serum S-100β levels
has been shown to be a sensitive, although nonspecific,
indicator of central nervous system damage (eg, stroke,
head injury).3-5 S-100β protein leaks from structurally
damaged nerve cells into cerebrospinal fluid and secon-
darily across the blood-brain barrier.6
Objectives: Over the past decade, the glial protein S-100β has been used
to detect cerebral injury in a number of clinical settings including car-
diac surgery. Previous investigations suggest that S-100β is capable of
identifying patients with cerebral dysfunction after cardiopulmonary
bypass. Whether detection of elevated levels S-100β reflects long-term
cognitive impairment remains to be shown. The present study evaluated
whether perioperative release of S-100β after coronary artery opera-
tions with cardiopulmonary bypass could predict early or late neu-
ropsychologic impairment. Methods: A total of 100 patients undergoing
elective coronary bypass without a previous history of neurologic events
were prospectively studied. To exclude noncerebral sources of S-100β,
we did not use cardiotomy suction or retransfusion of shed mediastinal
blood. Serial perioperative measurements of S-100β were performed
with the use of a new sensitive immunoluminometric assay up to 8 hours
after the operation. Patients underwent cognitive testing on a battery of
11 tests before the operation, before discharge from the hospital, and 3
months later. Results: No significant correlation was found between S-
100β release and neuropsychologic measures either 5 days or 3 months
after the operation. Conclusion: Despite using a sensitive immunolumi-
nometric assay of S-100β, we found no evidence to support the sugges-
tion that early release of S-100β may reflect long-term neurologic injury
capable of producing cognitive impairment. (J Thorac Cardiovasc Surg
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dysfunction and diabetes. All patients required between 2 and
5 bypass grafts. Patients were part of a randomized clinical
trial of a new coating agent of the CPB circuit (50 patients in
each group), the results of which showed no statistically sig-
nificant difference in S-100β and neuropsychologic mea-
sures. Each patient consented to a detailed 11-part neuropsy-
chologic examination, which was administered by a
psychologist (Table I). 
Anesthesia. On the day of the operation, patients were pre-
medicated with morphine (10-15 mg) and scopolamine (0.3-
0.4 mg). Anesthesia was induced with fentanyl (1 mg), pan-
curonium (8 mg), and etomidate (4-10 mg). Before CPB,
anesthesia was maintained with a combination of oxygen,
nitrous oxide, and halothane and during CPB with propofol (6
mg · kg–1 · h–1). 
Conduct of the operation. All operations were performed
with Cobe flat sheet membrane oxygenators and bypass cir-
cuits (COBE Cardiovascular Inc, Denver, Colo) and a pump
flow of 2.4 L · m–2 · min–1 at between 32°C and 36°C. Vent
suction was not used. The mean arterial pressure was main-
tained between 50 and 80 mm Hg and alpha-stat arterial car-
bon dioxide management was used. Myocardial protection
was achieved with antegrade crystalloid cardioplegia. Shed
mediastinal blood was minimized by careful surgery and was
discarded to avoid noncerebral sources of S-100β.
Anticoagulation during CPB was monitored with the activat-
ed clotting time (Hemochron 800; International Technidyne
Corp, Edison, NJ). Additional heparin was administered if the
activated clotting time was shorter than 400 seconds. Heparin
was neutralized by means of protamine chloride infusion (3
mg/kg) after the completion of CPB. 
S-100β analysis. Serum was analyzed for S-100β protein
concentration 24 hours before the operation (T1), 5 minutes
before beginning CPB but after heparin injection (T2), imme-
diately after termination of CPB but before protamine injec-
tion (T3), and 8 hours after the operation (T4). The serum or
heparinized plasma samples were stored at –80°C until ana-
lyzed. S-100β protein concentration was determined with the
use of a new, more sensitive monoclonal immunoluminomet-
ric method (sensitivity 0.02 µ/L) (Sangtec LIA 100, Sangtec
Medical AB, Bromma, Sweden). This assay method uses 3
monoclonal antibodies, SMST 12, SMSK 25, and SMSK 28,
to detect the beta chains in the betabeta and the alphabeta
dimers of S-100. Since S-100β is a calcium-binding protein,
plasma treated with ethylenediaminetetraacetic acid cannot
be used, but heparin does not affect the results, as we showed
in a separate unpublished validation study. The test is based
on sandwich formation of immobilized ant-S-100β antibody,
S-100β from the test sample and luminescence-labeled S-
100β antibody. The assay was performed according to the
manufacturer’s instructions and label was measured by
means of flash luminescence (Lumat LB 9507, EG & G,
Berthold, Germany).
Neuropsychologic and functional assessment. Each
patient underwent a comprehensive neuropsychologic exam-
ination administered by a research psychologist (S. White).
The National Adult Reading Test (NART) was used to esti-
mate pre-morbid intelligence. Tests were carried out preoper-
atively (1 day before the operation), before hospital discharge
(5 days after the operation), and again at 3 months after the
operation. All tests have been described in detail else-
where.12-16 Table I lists the neuropsychologic tests and pro-
vides a brief description of the cognitive domains evaluated. 
In addition to neuropsychologic performance, functional
and emotional measures were also measured before the oper-
ation and at 3 months’ follow-up. These tests were as follows:
1. Short Form-36 (multidimensional measure of subjective
health status)14
2. Health Complaints Scale (measures on somatic and cog-
nitive complaints)15
3. BADs Dysexecutive Questionnaire (measures a range
of problems commonly associated with dysexecutive impair-
ment)16
4. Hospital Anxiety and Depression Scale14
Statistical analysis. Clinical data were expressed as mean
and standard deviation. Blood test values were described as
mean and standard error of the mean. Neuropsychologic per-
formance was assessed by calculating the change scores (pre-
operative minus predischarge and preoperative minus follow-
up) for each patient on every test. Likewise, change scores
(preoperative minus follow-up) were also calculated for each
of the 4 functional measures. Change scores were then corre-
lated with the S-100β measures taken at each of the 4 differ-
ent time points. Computerized statistical analysis was under-
Table I. The neuropsychologic tests performed and a brief description of the cognitive domains evaluated
Neuropsychologic test Cognitive domains
Short Orientation–Memory- Concentration Test General cognitive orientation
Rey Auditory Verbal Learning Test (1. immediate; 2. delayed) Verbal memory
Grooved Pegboard Test Psychomotor speed and manual dexterity
Bells Cancellation Task Visual search and selective attention
Test A from the Adult Memory Information Processing Battery Speed of information processing
Trail Making Test A Attention shifting and psychomotor speed
Trail Making Test B Attention shifting, response inhibition, and psychomotor speed
Digit Span Forward Attention and auditory memory
Digit Span Backward Attention and visual imagery
Stroop Neuropsychological Screening Test Divided attention and response inhibition
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taken with the use of the SPSS for Windows (version 7) sta-
tistical program (SPSS, Inc, Chicago, Ill). Comparisons
between groups were done with the Mann-Whitney test for
unpaired data. Correlations between each of the mean S-100β
time points and age, CPB time, crossclamp time, blood loss,
blood transfusions, ventilatory times, and neuropsychologic
performance were calculated by means of the Pearson corre-
lation coefficient and, unless specified, adopted the .01 level
as significant given the large number of comparisons.
Because the distribution of S-100β values was generally
skewed, these data are presented as median, 25th, and 75th
percentiles.
Results
Patient characteristics and operative data are present-
ed in Table II. One patient required re-entry for exces-
sive postoperative bleeding and 1 had a stroke. After
initial recovery, 1 patient had bowel necrosis develop
and eventually died of multiple system failure (1%
mortality).
The serum S-100β protein concentration at each time
point is shown in Table III. In 90% of the patients the
preoperative (T1) S-100β concentration was below the
detection limit of the test (0.02 µ/L). The maximum
value (0.140 µ/L [0.060/0.273 µ/L]) was detected at
T4. There were 9 patients at this time point without
detectable S-100β levels, and in 7 patients the S-100β
protein could not be detected at any of the 4 time
points. The 1 patient who had a stroke had S-100β lev-
els as follows: T1, less than 0.02 µ/L; T2, 0.06 µL; T3,
0.25 µ/L; and T4, 0.09 µ/L. These levels were not sig-
nificantly different from those of the other patients.
Patients with undetectable levels of S-100β at T2 had
significant lower levels of S-100β at T3 (0.06 µ/L
[0/0.110 µ/L] vs 0.240 µ/L [0.120/0.330 µ/L]; P <
.0001) and at T4 (0.090 µ/L [0.030/0.152 µ/L] vs 0.220
µ/L [0.115/0.355 µ/L]; P < .0001).
We found no correlation between maximum S-100β
levels and crossclamp time (r = 0.024), perfusion time
(r = 0.025), ventilatory times (r = 0.065), blood trans-
fusions (r = 0.09), or total amount of fluid transfused (r
= 0.041). However, the prebypass levels of S-100β (T2)
correlated significantly with the postbypass level (T3)
(P < .0001, r = 0.57) and postoperative level (T4) (P =
.0001, r = 0.4). The postoperative S-100β (T4) values
also correlated with age (P = .017, r = 0.26). Inter-
estingly, those patients intubated for more than 5 hours
had a significantly higher maximum serum value of S-
100β than the others (0.240 µ/L [0.090/0.480 µ/L] vs
0.125 µ/L [0.060/0.240 µ/L]; P = .04).
Neuropsychologic performance. A total of 95
patients completed the preoperative assessment. The
remaining 5 were eliminated from follow-up. The
mean estimated IQ for the group was 108. Before hos-
pital discharge (5 days after the operation), 79 patients
could be assessed. Two patients were excluded because
of stroke and multiple organ failure. The remaining 14
patients declined for reasons of ill health. However, 3
months after the operation, 89 patients had completed
all tests. Pearson correlation coefficients for all serial
time points for S-100β versus neuropsychologic and func-
tional change scores are presented in Tables IV and V.
No significant correlations were found between the
S-100β level at any time point and neuropsychologic
change scores for any test. This was true even when the
level of significance was dropped to the .05 level.
Similarly, no significant correlations were found
between S-100β measures at any time point and func-
tional change scores. The correlation coefficients for
the functional measures are reported in Table VI.
Discussion 
It has been claimed that S-100β protein assay may be
a useful method of detecting cerebral injury after car-
diac surgery.8-10,17-19 However, to date no study has for-
mally shown a relationship between serum S-100β lev-
els and late neuropsychologic performance, the gold
standard for subtle cerebral injury. The results of the
present study did not show any relationship between S-
100β (at any of the serial time points) and early (5 days
Table II. Patient characteristics including operative
data
Variable Result
No. of patients 100
Age (y) 64 ± 8
CPB (min) 48 ± 14
Crossclamp time (min) 29 ± 19
Extubation (min) 250 ± 365
Postop blood loss (mL) 1155 ± 470
Blood transfused (mL) 435 ± 408
Data are expressed as mean ± standard deviation. CPB, Duration of car-
diopulmonary bypass; Extubation, time to extubation.
Table III. S-100 levels at the different time points (µg/L)
Time point Median 25th percentile 75th percentile
T1 <0.02 0 0
T2 <0.02 0 0.087
T3 0.120 0.043 0.297
T4 0.140 0.060 0.273
T1, S-100β concentration 24 hours before the operation; T2, 5 minutes before
beginning CPB but after heparin injection; T3, immediately after termination
of CPB but before protamine injection; T4, 8 hours after the operation.
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after the operation) or late (3 months after the opera-
tion) neuropsychologic outcome. This was also true for
the functional measures at 3 months’ follow-up.
The serum levels of S-100β after uncomplicated car-
diac operations follow a different pattern from those
after acute ischemic cerebral events, wherein peak val-
ues occur after 3 days.20,21 Studies on S-100β release
during and after CPB have shown peak S-100β levels
soon after perfusion, presumably resulting from tran-
sient increase in permeability of the blood-brain barri-
er as part of the inflammatory response.8-10,18,19
Joensson and associates9 showed that S-100β levels
immediately after CPB did not correlate with cerebral
outcome although grossly elevated levels of S-100β 48
hours after the operation were associated with clinical-
ly obvious stroke.9 The early release of S-100β after
cardiac surgery may thus be a transient serum elevation
without any relation to permanent neuronal damage.
However, the early S-100β studies were interpreted
without the awareness that S-100β from noncerebral
sources might confuse the issue by elevating overall
levels.11 In the present study, extracerebral S-100β was
reduced by discarding cardiotomy blood and not
retransfusing shed mediastinal blood, which has been
shown to contain high levels of S-100β.11 Conse-
quently, our S-100β levels were lower and also peaked
later than in earlier reports.8-10,18-19 Lower levels might
also be caused by other factors. We used a new, highly
sensitive immunoluminometric assay test capable of
detecting much lower levels of S-100β, whereas in ear-
lier studies levels of S-100β below 0.2 µ/L were not
detectable. Consequently, more patients in our study
had detectable levels of S-100β. As most of these were
at or below the previous less-sensitive level, it is likely
that they contributed to the lowering of the mean lev-
els, since previous studies in which less-sensitive
Table IV. Preoperative versus hospital discharge neuropsychologic change scores correlated against S-100 levels
at the different time points
Neuropsychologic test T1 T2 T3 T4
Short Orientation–Memory-Concentration Test 0.034 0.120 0.067 0.051
Rey Auditory Verbal Learning Test: Immediate Recall 0.014 –0.156 –0.064 0.054
Rey Auditory Verbal Learning Test: Delayed Recall –0.147 –0.130 –0.190 –0.093
Grooved Pegboard Test 0.050 –0.016 0.074 0.053
Bells Cancellation Task 0.085 0.072 0.156 0.159
Test A from Adult Memory Information Processing Battery 0.100 –0.021 0.114 0.038
Trail Making Test A –0.172 –0.061 –0.133 –0.117
Trail Making Test B 0.005 –0.207 –0.166 –0.151
Digit Span Forward 0.172 0.125 –0.024 –0.122
Digit Span Backward –0.002 –0.110 –0.175 –0.202
Stroop Neuropsychological Screening Test 0.135 0.114 0.159 0.150
Figures indicate correlation coefficients. T1, S-100β concentration 24 hours before the operation; T2, 5 minutes before beginning CPB but after heparin injection;
T3, immediately after termination of CPB but before protamine injection; T4, 8 hours after the operation.
Table V. Preoperative versus 3 months’ follow-up neuropsychologic change scores correlated against S-100 levels
at the different time points
Neuropsychologic test T1 T2 T3 T4
Short Orientation–Memory-Concentration Test 0.006 –0.011 –0.160 –0.130
Rey Auditory Verbal Learning Test: Immediate Recall –0.043 –0.038 –0.059 –0.015
Rey Auditory Verbal Learning Test: Delayed Recall 0.043 –0.056 –0.192 –0.080
Grooved Pegboard Test –0.077 –0.100 –0.003 –0.039
Bells Cancellation Task 0.002 –0.019 –0.132 –0.053
Test A from Adult Memory Information Processing Battery 0.037 –0.005 0.068 0.061
Trail Making Test A –0.123 –0.083 –0.033 0.066
Trail Making Test B 0.027 –0.031 0.050 0.106
Digit Span Forward 0.188 0.154 –0.052 –0.130
Digit Span Backward 0.069 0.007 –0.047 –0.136
Stroop Neuropsychological Screening Test 0.064 –0.012 0.148 0.074
Figures indicate correlation coefficients. T1, S-100β concentration 24 hours before the operation; T2, 5 minutes before beginning CPB but after heparin injection;
T3, immediately after termination of CPB but before protamine injection; T4, 8 hours after the operation.
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assays were used did not always include patients with
undetectable S-100β levels.
Grocott and colleagues10 described a weak but sig-
nificant relationship between cerebral microemboli and
S-100β levels. In an experimental study, blood aspirat-
ed from the surgical field during CPB and reinfused
into dogs generated a greater density of small capillary
and arterial dilatations in the brain than CPB without
cardiotomy suction.23 The presence of so-called small
capillary and arterial dilatations was first demonstrated
by Moody and colleagues24 in autopsy specimens from
patients who had undergone cardiac operations with
CPB. There is evidence to suggest that lipid microem-
bolism is the cause of these diffuse cerebral changes.25
We have also shown that an arterial line filter can sig-
nificantly reduce levels of S-100β, although this early
investigation was performed with cardiotomy suction
and the less-sensitive S-100β assay.26
A recent study by Backstroem and associates,22 using
a kinetic model employing elimination rates of S-100β
during the first 5 hours after operation, found a positive
correlation with early adverse cognitive outcome. The
authors proposed early S-100β elimination rate (as an
expression of postbypass release) in preference to
absolute levels to correct for contamination from
extracerebral sources.9 However, the formula to calcu-
late elimination rate requires a progressive decrease in
postoperative levels, whereas our study without car-
diotomy suction shows an increase over this time
frame. Consequently, for our study the calculation
would have been meaningless for most patients.
Appearance of S-100β in serum after CPB may indi-
cate cellular damage, increased permeability of the
blood-brain barrier, or both. Transient permeability of
the blood-brain barrier to S-100β protein could be
caused by the inflammatory response generated by
CPB itself. Since the development of inflammation is
time related, we might expect a positive correlation
between perfusion time and S-100β release. In fact,
correlation between perfusion time and S-100β levels
has been an inconstant finding.8-10,18,19,27,28 Our present
study found no relationship between S-100β and perfu-
sion time, although in general the duration of CPB was
short. However, we did find a significant correlation
between the prebypass value and the postbypass levels,
and patients without detectable prebypass levels had
significantly lower levels of S-100β afterward, irre-
spective of perfusion time. These findings suggest that
factors other than perfusion time may influence the
release of S-100β. Surgical injury and the anesthesia
may well contribute to this release, and differences
have been shown in valve, aortic aneurysm, and
hypothermic circulatory arrest patients where S-100β
levels are greater and remain significantly higher for
between 5 and 48 hours.18 In open cardiac operations
(as opposed to coronary operations), the relationship
between S-100β and neuropsychologic outcome might
be different irrespective of the contribution of cardioto-
my suction.
The finding of significantly higher S-100β levels in
patients requiring ventilation for more than 5 hours is
interesting and consistent with a recent report claiming
a relationship between postoperative S-100β levels and
prolonged intubation.28 Cerebral edema has been
demonstrated within an hour of CPB by magnetic res-
onance scanning in patients undergoing routine coro-
nary bypass.29 The swelling is variable and may simi-
larly reflect transient change in permeability of the
blood-brain barrier without injury to the brain itself.
The transient increase in S100β levels may then repre-
sent a reversible increase in the permeability of cellular
and vascular membranes as opposed to structural neu-
Table VI. Preoperative versus 3 months’ follow-up functional change scores correlated against S-100 levels at the
different time points
Functional test T1 T2 T3 T4
Short Form-36 –0.161 0.014 0.105 0.051
Health Complaints Scale:
Somatic Measures –0 .086 –0.121 –0 .161 –0.123
Cognitive Measures –0.011 0.095 0.028 0.071
Hospital Anxiety and Depression Scale:
Anxiety –0.036 0.011 –0 .112 –0.041
Depression –0.097 –0.097 –0.145 –0.112
BADS Dysexecutive Questionnaire:
Self –0.080 0.102 0.097 0.016
Other 0.058 –0.125 –0.064 –0.047
Figures indicate correlation coefficients. T1, S-100β concentration 24 hours before the operation; T2, 5 minutes before beginning CPB but after heparin injection;
T3, immediately after termination of CPB but before protamine injection; T4, 8 hours after the operation.
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ronal damage. All patients having coronary operations
in this study were subjected to fast track and early extu-
bation protocols (irrespective of age), so that shorter
extubation time reflected early awaking and conscious
awareness.30
In summary, we were unable to demonstrate any cor-
relation between serum S-100β protein levels and early
or late neuropsychologic impairment after elective
coronary operations with CPB. It is possible that the
transient passage of S-100β from cerebrospinal fluid to
serum bears little relationship to the type of neuronal
injury necessary to produce impairment of neuropsy-
chologic and functional measures.
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